Lucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.14, Iss.3, 2005-03, pp. : 329-334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lucinactant in neonatal respiratory distress syndrome: profile report

By Adis International Limited

Drugs & Therapy Perspectives, Vol. 21, Iss. 10, 2005-10 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

Lucinactant for the prevention of respiratory distress syndrome in premature infants

By Jordan Brian K Donn Steven M

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 115-121

Informa Healthcare

Access to resources Recommend Favorite

The Russian Ministry of Health has approved a surfactant-BL product for the treatment of respiratory distress syndrome in adults

Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Acute respiratory distress syndrome following treatment for babesiosis

By Jr Ryland P Byrd Roy Thomas M

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. : 1541-1542

Informa Healthcare

Access to resources Recommend Favorite

Current Perspectives on the Drug Treatment of Neonatal Respiratory Distress Syndrome

By Sweet D.G. Halliday H.L.

Pediatric Drugs, Vol. 1, Iss. 1, 1999-01 ,pp. : 19-30

Adis International

Access to resources Recommend Favorite